Startup
MicroMED owns a novel and powerful MEMS (Micro Electro Mechanical System) micropump platform technology. This proprietary technology makes possible a flexible customization service for a wide variety of drug delivery applications: from implantable to wearable devices, animal to human, small (mm) to large (cm) device footprint, slow (nL/Hr) to fast (mL/sec) delivery rate, small dose (pg) to large dose (g), small molecule to biologics drug compatibility, and 510k to 505b2 regulatory paths.
Guidance Rendered
-

- Introduction and matching of six venture capital companies with the startup.
- Mentoring on U.S. regulations.
- Assistance in attending such international fairs as PDA and BioAsia.
- Assistance in connecting with clinicians and hospitals.
- Assistance in gaining access to the MOEA’s Small Business Innovation Research (SBIR) program.
- Referral of international contract manufacturers.